国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Vibrio fischeri 3-isopropylmalate dehydratase small subunit (leuD) CSB-YP466293VFC
CSB-EP466293VFC
CSB-BP466293VFC
CSB-MP466293VFC
CSB-EP466293VFC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio fischeri Sulfate adenylyltransferase subunit 1 (cysN) CSB-YP466294VFC
CSB-EP466294VFC
CSB-BP466294VFC
CSB-MP466294VFC
CSB-EP466294VFC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio fischeri Periplasmic nitrate reductase (napA), partial CSB-YP466295VFC
CSB-EP466295VFC
CSB-BP466295VFC
CSB-MP466295VFC
CSB-EP466295VFC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella dublin 4-hydroxy-3-methylbut-2-enyl diphosphate reductase (ispH) CSB-YP466296SWN
CSB-EP466296SWN
CSB-BP466296SWN
CSB-MP466296SWN
CSB-EP466296SWN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella dublin L-carnitine/gamma-butyrobetaine antiporter (caiT), partial CSB-YP466297SWN
CSB-EP466297SWN
CSB-BP466297SWN
CSB-MP466297SWN
CSB-EP466297SWN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella dublin UPF0482 protein ynfB (ynfB) CSB-YP466298SWN
CSB-EP466298SWN
CSB-BP466298SWN
CSB-MP466298SWN
CSB-EP466298SWN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella dublin Bifunctional protein HldE (hldE) CSB-YP466299SWN
CSB-EP466299SWN
CSB-BP466299SWN
CSB-MP466299SWN
CSB-EP466299SWN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella dublin UPF0597 protein yhaM (yhaM) CSB-YP466300SWN
CSB-EP466300SWN
CSB-BP466300SWN
CSB-MP466300SWN
CSB-EP466300SWN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella dublin Ribosomal RNA large subunit methyltransferase E (rlmE) CSB-YP466301SWN
CSB-EP466301SWN
CSB-BP466301SWN
CSB-MP466301SWN
CSB-EP466301SWN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella dublin UDP-N-acetylmuramate--L-alanine ligase (murC) CSB-YP466302SWN
CSB-EP466302SWN
CSB-BP466302SWN
CSB-MP466302SWN
CSB-EP466302SWN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella dublin DNA replication terminus site-binding protein (tus) CSB-YP466303SWN
CSB-EP466303SWN
CSB-BP466303SWN
CSB-MP466303SWN
CSB-EP466303SWN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella dublin Electron transport complex protein RnfD (rnfD), partial CSB-YP466304SWN
CSB-EP466304SWN
CSB-BP466304SWN
CSB-MP466304SWN
CSB-EP466304SWN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella dublin Sulfoxide reductase heme-binding subunit YedZ (yedZ), partial CSB-YP466305SWN1
CSB-EP466305SWN1
CSB-BP466305SWN1
CSB-MP466305SWN1
CSB-EP466305SWN1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella dublin Sugar fermentation stimulation protein A (sfsA) CSB-YP466306SWN
CSB-EP466306SWN
CSB-BP466306SWN
CSB-MP466306SWN
CSB-EP466306SWN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella dublin UPF0325 protein yaeH (yaeH) CSB-YP466307SWN
CSB-EP466307SWN
CSB-BP466307SWN
CSB-MP466307SWN
CSB-EP466307SWN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella dublin Phenylalanine--tRNA ligase alpha subunit (pheS) CSB-YP466308SWN
CSB-EP466308SWN
CSB-BP466308SWN
CSB-MP466308SWN
CSB-EP466308SWN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella dublin N-succinylglutamate 5-semialdehyde dehydrogenase (astD) CSB-YP466309SWN
CSB-EP466309SWN
CSB-BP466309SWN
CSB-MP466309SWN
CSB-EP466309SWN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella dublin 50S ribosomal protein L30 (rpmD) CSB-YP466310SWN
CSB-EP466310SWN
CSB-BP466310SWN
CSB-MP466310SWN
CSB-EP466310SWN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella dublin 30S ribosomal protein S17 (rpsQ) CSB-YP466311SWN
CSB-EP466311SWN
CSB-BP466311SWN
CSB-MP466311SWN
CSB-EP466311SWN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella dublin Protein slyX (slyX) CSB-YP466312SWN
CSB-EP466312SWN
CSB-BP466312SWN
CSB-MP466312SWN
CSB-EP466312SWN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>